Effects of rosiglitazone on serum ghrelin and peptide YY [tyrosine tyrosine] levels in diabetic women
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 May 2008 Biomarkers information updated
- 08 May 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 05 Sep 2007 New trial record.